Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ELI-002 7P |
| Synonyms | |
| Therapy Description |
ELI-002 7P is a cancer vaccine comprising Amphiphile-modified KRAS G12D, G12R, G12V, G12C, G12A, G12S and G13D peptides, which potentially induces antitumor immune response against KRAS mutant tumor cells (Journal for ImmunoTherapy of Cancer 2024; 12, Suppl 3). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ELI-002 7P | ELI-0027P|ELI-002-7P|ELI002 7P | ELI-002 7P is a cancer vaccine comprising Amphiphile-modified KRAS G12D, G12R, G12V, G12C, G12A, G12S and G13D peptides, which potentially induces antitumor immune response against KRAS mutant tumor cells (Journal for ImmunoTherapy of Cancer 2024; 12, Suppl 3). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|